| Product NDC: | 37000-731 |
| Proprietary Name: | SK-II Facial Treatment |
| Non Proprietary Name: | Octinoxate |
| Active Ingredient(s): | 10.9; 81.64; 42.728 mg/mL; mg/mL; mg/mL & nbsp; Octinoxate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 37000-731 |
| Labeler Name: | Procter & Gamble Manufacturing Co. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20091101 |
| Package NDC: | 37000-731-30 |
| Package Description: | 1 BOTTLE, DISPENSING in 1 CARTON (37000-731-30) > 30 mL in 1 BOTTLE, DISPENSING |
| NDC Code | 37000-731-30 |
| Proprietary Name | SK-II Facial Treatment |
| Package Description | 1 BOTTLE, DISPENSING in 1 CARTON (37000-731-30) > 30 mL in 1 BOTTLE, DISPENSING |
| Product NDC | 37000-731 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20091101 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Procter & Gamble Manufacturing Co. |
| Substance Name | ENSULIZOLE; OCTINOXATE; ZINC OXIDE |
| Strength Number | 10.9; 81.64; 42.728 |
| Strength Unit | mg/mL; mg/mL; mg/mL |
| Pharmaceutical Classes |